Noel Greenberger

Noel Greenberger is the CEO of Nob Hill Therapeutics, an Albuquerque-based respiratory company building DryNeb, a dry powder nebulizer that pushes high therapeutic doses deep into the lungs regardless of a patient's breathing capacity. A Wharton MBA and Northwestern-trained industrial engineer, he spent years commercializing respiratory medicines at Sandoz, ran commercial strategy at Vertice Pharma, and consulted at McKinsey and ZS Associates before taking the helm of Nob Hill in 2022. Under his watch the company won a $1.73M HHS Phase II grant and closed a $3M Series A in 2024.